Subaru Corp said it would recall more vehicles sold in the Japan domestic market on new cases of inspection cheating, and cautioned that rising recall costs would lop off about a quarter from its annual profit forecast.
Shares in Subaru, already reeling from a series of recalls for issues ranging from faulty components to inspection do-overs, fell 5 percent to a four-year low on Monday after news of the fresh recalls and the bleak outlook.
The company, the smallest among Japan’s major automakers, said it would recall around 100,000 vehicles, including its popular Impreza sedan, after discovering that final tests for components including brakes were not conducted properly. Vehicles sold overseas will not be affected.
“It’s unforgivable that these inspection-related issues are continuing,” CEO Tomomi Nakamura said at a briefing, while repeatedly adding that the latest recall would be the last related to testing misconduct.
Recall-related costs were the main driver of the loss, while global sales fell 6 percent over the quarter due to weak demand in the United States — its biggest market, where overall demand has cooled since record-high sales in 2016.
Last month, Subaru nearly halved its first-half operating profit view, citing higher quality-related costs. It later announced a global recall of around 400,000 vehicles, including its Forester SUV and Impreza sedan, to fix a design flaw in the engines’ valve springs.
“I have already heard from overseas that this recall could hit our brand image,” Nakamura said.
U.S. market troubles
Shares of Subaru, which so far has not been able to improve compliance at its plants, have shed almost 20 percent of their value this year, on track for a third straight annual drop — pressured also by bleaker prospects in the United States.
Subaru is also bracing for a possible hike in U.S. tariffs on Japanese auto imports, which would hurt given it imports half of the vehicles it sells in the United States from Japan. However, it has started production of its new Ascent three-row crossover in its plant in Indiana, which it hopes will be a big seller in the American market.